|
1
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lendahl U, Lee KL, Yang H and Poellinger
L: Generating specificity and diversity in the transcriptional
response to hypoxia. Nat Rev Genet. 10:821–832. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pastorek J and Pastorekova S:
Hypoxia-induced carbonic anhydrase IX as a target for cancer
therapy: From biology to clinical use. Semin Cancer Biol. 31:52–64.
2015. View Article : Google Scholar
|
|
4
|
Ditte P, Dequiedt F, Svastova E, Hulikova
A, Ohradanova-Repic A, Zatovicova M, Csaderova L, Kopacek J,
Supuran CT, Pastorekova S, et al: Phosphorylation of carbonic
anhydrase IX controls its ability to mediate extracellular
acidification in hypoxic tumors. Cancer Res. 71:7558–7567. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Svastova E, Witarski W, Csaderova L, Kosik
I, Skvarkova L, Hulikova A, Zatovicova M, Barathova M, Kopacek J,
Pastorek J, et al: Carbonic anhydrase IX interacts with bicarbonate
transporters in lamellipodia and increases cell migration via its
catalytic domain. J Biol Chem. 287:3392–3402. 2012. View Article : Google Scholar :
|
|
6
|
Csaderova L, Debreova M, Radvak P, Stano
M, Vrestiakova M, Kopacek J, Pastorekova S and Svastova E: The
effect of carbonic anhydrase IX on focal contacts during cell
spreading and migration. Front Physiol. 4:2712013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wykoff CC, Beasley NJ, Watson PH, Turner
KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell
PH, et al: Hypoxia-inducible expression of tumor-associated
carbonic anhydrases. Cancer Res. 60:7075–7083. 2000.
|
|
8
|
Zatovicova M, Jelenska L, Hulikova A,
Csaderova L, Ditte Z, Ditte P, Goliasova T, Pastorek J and
Pastorekova S: Carbonic anhydrase IX as an anticancer therapy
target: Preclinical evaluation of internalizing monoclonal antibody
directed to catalytic domain. Curr Pharm Des. 16:3255–3263. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dehne N and Brüne B: HIF-1 in the
inflammatory microenvironment. Exp Cell Res. 315:1791–1797. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Eltzschig HK and Carmeliet P: Hypoxia and
inflammation. N Engl J Med. 364:656–665. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barnes PJ and Karin M: Nuclear
factor-kappaB: A pivotal transcription factor in chronic
inflammatory diseases. N Engl J Med. 336:1066–1071. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Taylor CT: Interdependent roles for
hypoxia inducible factor and nuclear factor-kappaB in hypoxic
inflammation. J Physiol. 586:4055–4059. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen ZJ, Parent L and Maniatis T:
Site-specific phosphorylation of IkappaBalpha by a novel
ubiquitination-dependent protein kinase activity. Cell. 84:853–862.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Israël A: The IKK complex: An integrator
of all signals that activate NF-kappaB? Trends Cell Biol.
10:129–133. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rutz HP: Effects of corticosteroid use on
treatment of solid tumours. Lancet. 360:1969–1970. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rutz HP and Herr I: Interference of
glucocorticoids with apoptosis signaling and host-tumor
interactions. Cancer Biol Ther. 3:715–718. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schaaf MJ and Cidlowski JA: Molecular
mechanisms of glucocorticoid action and resistance. J Steroid
Biochem Mol Biol. 83:37–48. 2002. View Article : Google Scholar
|
|
19
|
Kim H, Lee JM, Park JS, Jo SA, Kim YO, Kim
CW and Jo I: Dexamethasone coordinately regulates angiopoietin-1
and VEGF: A mechanism of glucocorticoid-induced stabilization of
blood-brain barrier. Biochem Biophys Res Commun. 372:243–248. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hata Y, Sassa Y, Kita T, Miura M, Kano K,
Kawahara S, Arita R, Nakao S, Shih JL and Ishibashi T: Vascular
endothelial growth factor expression by hyalocytes and its
regulation by glucocorticoid. Br J Ophthalmol. 92:1540–1544. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Iwai A, Fujii Y, Kawakami S, Takazawa R,
Kageyama Y, Yoshida MA and Kihara K: Down-regulation of vascular
endothelial growth factor in renal cell carcinoma cells by
glucocorticoids. Mol Cell Endocrinol. 226:11–17. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Machein MR, Kullmer J, Rönicke V, Machein
U, Krieg M, Damert A, Breier G, Risau W and Plate KH: Differential
downregulation of vascular endothelial growth factor by
dexamethasone in normoxic and hypoxic rat glioma cells. Neuropathol
Appl Neurobiol. 25:104–112. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yano A, Fujii Y, Iwai A, Kageyama Y and
Kihara K: Glucocorticoids suppress tumor angiogenesis and in vivo
growth of prostate cancer cells. Clin Cancer Res. 12:3003–3009.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu Y, Lucia K, Lange M, Kuhlen D, Stalla
GK and Renner U: Hypoxia inducible factor-1 is involved in growth
factor, glucocorticoid and hypoxia mediated regulation of vascular
endothelial growth factor-A in human meningiomas. J Neurooncol.
119:263–273. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bao Y, Lv F and Ma Y: Effect of
dexamethasone on expression of hypoxia inducible factor-1α and
vascular endothelial growth factor in hypoxic mice. Zhongguo Fei Ai
Za Zhi. 9:143–146. 2006.(In Chinese). PubMed/NCBI
|
|
26
|
Leonard MO, Godson C, Brady HR and Taylor
CT: Potentiation of glucocorticoid activity in hypoxia through
induction of the glucocorticoid receptor. J Immunol. 174:2250–2257.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kopacek J, Barathova M, Dequiedt F,
Sepelakova J, Kettmann R, Pastorek J and Pastorekova S: MAPK
pathway contributes to density- and hypoxia-induced expression of
the tumor-associated carbonic anhydrase IX. Biochim Biophys Acta.
1729:41–49. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kaluz S, Kaluzová M, Chrastina A, Olive
PL, Pastoreková S, Pastorek J, Lerman MI and Stanbridge EJ: Lowered
oxygen tension induces expression of the hypoxia marker MN/carbonic
anhydrase IX in the absence of hypoxia-inducible factor 1 alpha
stabilization: A role for phosphatidylinositol 3′-kinase. Cancer
Res. 62:4469–4477. 2002.PubMed/NCBI
|
|
29
|
Cartharius K, Frech K, Grote K, Klocke B,
Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M and Werner T:
MatInspector and beyond: Promoter analysis based on transcription
factor binding sites. Bioinformatics. 21:2933–2942. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Quandt K, Frech K, Karas H, Wingender E
and Werner T: MatInd and MatInspector: New fast and versatile tools
for detection of consensus matches in nucleotide sequence data.
Nucleic Acids Res. 23:4878–4884. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Abrahám IM, Meerlo P and Luiten PG:
Concentration dependent actions of glucocorticoids on neuronal
viability and survival. Dose Response. 4:38–54. 2006. View Article : Google Scholar
|
|
32
|
Cianchi F, Vinci MC, Supuran CT, Peruzzi
B, De Giuli P, Fasolis G, Perigli G, Pastorekova S, Papucci L, Pini
A, et al: Selective inhibition of carbonic anhydrase IX decreases
cell proliferation and induces ceramide-mediated apoptosis in human
cancer cells. J Pharmacol Exp Ther. 334:710–719. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dubois L, Peeters S, Lieuwes NG, Geusens
N, Thiry A, Wigfield S, Carta F, McIntyre A, Scozzafava A, Dogné
JM, et al: Specific inhibition of carbonic anhydrase IX activity
enhances the in vivo therapeutic effect of tumor irradiation.
Radiother Oncol. 99:424–431. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Morris JC, Chiche J, Grellier C, Lopez M,
Bornaghi LF, Maresca A, Supuran CT, Pouysségur J and Poulsen SA:
Targeting hypoxic tumor cell viability with carbohydrate-based
carbonic anhydrase IX and XII inhibitors. J Med Chem. 54:6905–6918.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ikeda Y, Carson BS and Long DM: The
effects of topical dexamethasone on experimental brain tumors and
peritumoral brain edema. Acta Neurochir Suppl (Wien). 60:397–399.
1994.
|
|
36
|
Maxwell PH, Wiesener MS, Chang GW,
Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER and
Ratcliffe PJ: The tumour suppressor protein VHL targets
hypoxia-inducible factors for oxygen-dependent proteolysis. Nature.
399:271–275. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wiesener MS, Turley H, Allen WE, Willam C,
Eckardt KU, Talks KL, Wood SM, Gatter KC, Harris AL, Pugh CW, et
al: Induction of endothelial PAS domain protein-1 by hypoxia:
Characterization and comparison with hypoxia-inducible
factor-1alpha. Blood. 92:2260–2268. 1998.PubMed/NCBI
|
|
38
|
Culver C, Sundqvist A, Mudie S, Melvin A,
Xirodimas D and Rocha S: Mechanism of hypoxia-induced NF-kappaB.
Mol Cell Biol. 30:4901–4921. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Koong AC, Chen EY and Giaccia AJ: Hypoxia
causes the activation of nuclear factor kappa B through the
phosphorylation of I kappa B alpha on tyrosine residues. Cancer
Res. 54:1425–1430. 1994.PubMed/NCBI
|
|
40
|
Badruddoja MA, Krouwer HG, Rand SD, Rebro
KJ, Pathak AP and Schmainda KM: Antiangiogenic effects of
dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood
volume maps. Neuro Oncol. 5:235–243. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
van Uden P, Kenneth NS and Rocha S:
Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem
J. 412:477–484. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Iyer NV, Leung SW and Semenza GL: The
human hypoxia-inducible factor 1alpha gene: HIF1A structure and
evolutionary conservation. Genomics. 52:159–165. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Minet E, Ernest I, Michel G, Roland I,
Remacle J, Raes M and Michiels C: HIF1A gene transcription is
dependent on a core promoter sequence encompassing activating and
inhibiting sequences located upstream from the transcription
initiation site and cis elements located within the 5′UTR. Biochem
Biophys Res Commun. 261:534–540. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Niu G, Briggs J, Deng J, Ma Y, Lee H,
Kortylewski M, Kujawski M, Kay H, Cress WD, Jove R, et al: Signal
transducer and activator of transcription 3 is required for
hypoxia-inducible factor-1alpha RNA expression in both tumor cells
and tumor-associated myeloid cells. Mol Cancer Res. 6:1099–1105.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bhattacharya S, Michels CL, Leung MK,
Arany ZP, Kung AL and Livingston DM: Functional role of p35srj, a
novel p300/CBP binding protein, during transactivation by HIF-1.
Genes Dev. 13:64–75. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hudson CC, Liu M, Chiang GG, Otterness DM,
Loomis DC, Kaper F, Giaccia AJ and Abraham RT: Regulation of
hypoxia-inducible factor 1alpha expression and function by the
mammalian target of rapamycin. Mol Cell Biol. 22:7004–7014. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Treins C, Giorgetti-Peraldi S, Murdaca J,
Semenza GL and Van Obberghen E: Insulin stimulates
hypoxia-inducible factor 1 through a phosphatidylinositol
3-kinase/target of rapamycin-dependent signaling pathway. J Biol
Chem. 277:27975–27981. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang H, Kubica N, Ellisen LW, Jefferson LS
and Kimball SR: Dexamethasone represses signaling through the
mammalian target of rapamycin in muscle cells by enhancing
expression of REDD1. J Biol Chem. 281:39128–39134. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhou J, Schmid T, Frank R and Brüne B:
PI3K/Akt is required for heat shock proteins to protect
hypoxia-inducible factor 1alpha from pVHL-independent degradation.
J Biol Chem. 279:13506–13513. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Katschinski DM, Le L, Schindler SG, Thomas
T, Voss AK and Wenger RH: Interaction of the PAS B domain with
HSP90 accelerates hypoxia-inducible factor-1alpha stabilization.
Cell Physiol Biochem. 14:351–360. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Maheshwari M, Bhutani S, Das A, Mukherjee
R, Sharma A, Kino Y, Nukina N and Jana NR: Dexamethasone induces
heat shock response and slows down disease progression in mouse and
fly models of Huntington's disease. Hum Mol Genet. 23:2737–2751.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lim W, Park C, Shim MK, Lee YH, Lee YM and
Lee Y: Glucocorticoids suppress hypoxia-induced COX-2 and hypoxia
inducible factor-1α expression through the induction of
glucocorticoid-induced leucine zipper. Br J Pharmacol. 171:735–745.
2014. View Article : Google Scholar :
|
|
53
|
Leis H, Page A, Ramírez A, Bravo A,
Segrelles C, Paramio J, Barettino D, Jorcano JL and Pérez P:
Glucocorticoid receptor counteracts tumorigenic activity of Akt in
skin through interference with the phosphatidylinositol 3-kinase
signaling pathway. Mol Endocrinol. 18:303–311. 2004. View Article : Google Scholar
|
|
54
|
Box AH and Demetrick DJ: Cell cycle kinase
inhibitor expression and hypoxia-induced cell cycle arrest in human
cancer cell lines. Carcinogenesis. 25:2325–2335. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Mottet D, Dumont V, Deccache Y, Demazy C,
Ninane N, Raes M and Michiels C: Regulation of hypoxia-inducible
factor-1alpha protein level during hypoxic conditions by the
phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta
pathway in HepG2 cells. J Biol Chem. 278:31277–31285. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
De Bosscher K, Vanden Berghe W and
Haegeman G: The interplay between the glucocorticoid receptor and
nuclear factor-kappaB or activator protein-1: Molecular mechanisms
for gene repression. Endocr Rev. 24:488–522. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Kaluz S, Kaluzová M, Opavský R,
Pastoreková S, Gibadulinová A, Dequiedt F, Kettmann R and Pastorek
J: Transcriptional regulation of the MN/CA 9 gene coding for the
tumor-associated carbonic anhydrase IX. Identification and
characterization of a proximal silencer element. J Biol Chem.
274:32588–32595. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ashburner BP, Westerheide SD and Baldwin
AS Jr: The p65 (RelA) subunit of NF-kappaB interacts with the
histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to
negatively regulate gene expression. Mol Cell Biol. 21:7065–7077.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Baetz D, Regula KM, Ens K, Shaw J, Kothari
S, Yurkova N and Kirshenbaum LA: Nuclear factor-kappaB-mediated
cell survival involves transcriptional silencing of the
mitochondrial death gene BNIP3 in ventricular myocytes.
Circulation. 112:3777–3785. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Datta De D, Datta A, Bhattacharjya S and
Roychoudhury S: NF-kappaB mediated transcriptional repression of
acid modifying hormone gastrin. PLoS One. 8:e734092013. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Swietach P, Wigfield S, Cobden P, Supuran
CT, Harris AL and Vaughan-Jones RD: Tumor-associated carbonic
anhydrase 9 spatially coordinates intracellular pH in
three-dimensional multicellular growths. J Biol Chem.
283:20473–20483. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Swietach P, Patiar S, Supuran CT, Harris
AL and Vaughan-Jones RD: The role of carbonic anhydrase 9 in
regulating extracellular and intracellular ph in three-dimensional
tumor cell growths. J Biol Chem. 284:20299–20310. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Hulikova A, Harris AL, Vaughan-Jones RD
and Swietach P: Regulation of intracellular pH in cancer cell lines
under normoxia and hypoxia. J Cell Physiol. 228:743–752. 2013.
View Article : Google Scholar
|
|
64
|
Ditte Z, Ditte P, Labudova M, Simko V,
Iuliano F, Zatovicova M, Csaderova L, Pastorekova S and Pastorek J:
Carnosine inhibits carbonic anhydrase IX-mediated extracellular
acidosis and suppresses growth of HeLa tumor xenografts. BMC
Cancer. 14:3582014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Chiche J, Ilc K, Laferrière J, Trottier E,
Dayan F, Mazure NM, Brahimi-Horn MC and Pouysségur J:
Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell
growth by counteracting acidosis through the regulation of the
intracellular pH. Cancer Res. 69:358–368. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
McIntyre A, Patiar S, Wigfield S, Li JL,
Ledaki I, Turley H, Leek R, Snell C, Gatter K, Sly WS, et al:
Carbonic anhydrase IX promotes tumor growth and necrosis in vivo
and inhibition enhances anti-VEGF therapy. Clin Cancer Res.
18:3100–3111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Ivanova L, Zandberga E, Siliņa K, Kalniņa
Z, Ābols A, Endzeliņš E, Vendina I, Romanchikova N, Hegmane A,
Trapencieris P, et al: Prognostic relevance of carbonic anhydrase
IX expression is distinct in various subtypes of breast cancer and
its silencing suppresses self-renewal capacity of breast cancer
cells. Cancer Chemother Pharmacol. 75:235–246. 2015. View Article : Google Scholar
|
|
68
|
Mattern J, Büchler MW and Herr I: Cell
cycle arrest by glucocorticoids may protect normal tissue and solid
tumors from cancer therapy. Cancer Biol Ther. 6:1345–1354. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Takada Y, Bhardwaj A, Potdar P and
Aggarwal BB: Nonsteroidal anti-inflammatory agents differ in their
ability to suppress NF-kappaB activation, inhibition of expression
of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell
proliferation. Oncogene. 23:9247–9258. 2004.PubMed/NCBI
|
|
70
|
Wang ML, Chiou SH and Wu CW: Targeting
cancer stem cells: Emerging role of Nanog transcription factor.
Onco Targets Ther. 6:1207–1220. 2013.PubMed/NCBI
|
|
71
|
Dang CV: c-Myc target genes involved in
cell growth, apoptosis, and metabolism. Mol Cell Biol. 19:1–11.
1999. View Article : Google Scholar
|
|
72
|
Lavia P and Jansen-Dürr P: E2F target
genes and cell-cycle checkpoint control. BioEssays. 21:221–230.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Meyer C, Pries R and Wollenberg B:
Established and novel NF-κB inhibitors lead to downregulation of
TLR3 and the proliferation and cytokine secretion in HNSCC. Oral
Oncol. 47:818–826. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Mayer A, Schneider F, Vaupel P, Sommer C
and Schmidberger H: Differential expression of HIF-1 in
glioblastoma multiforme and anaplastic astrocytoma. Int J Oncol.
41:1260–1270. 2012.PubMed/NCBI
|
|
75
|
Hussain SA, Ganesan R, Reynolds G, Gross
L, Stevens A, Pastorek J, Murray PG, Perunovic B, Anwar MS,
Billingham L, et al: Hypoxia-regulated carbonic anhydrase IX
expression is associated with poor survival in patients with
invasive breast cancer. Br J Cancer. 96:104–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Wykoff CC, Beasley N, Watson PH, Campo L,
Chia SK, English R, Pastorek J, Sly WS, Ratcliffe P and Harris AL:
Expression of the hypoxia-inducible and tumor-associated carbonic
anhydrases in ductal carcinoma in situ of the breast. Am J Pathol.
158:1011–1019. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Chu CY, Jin YT, Zhang W, Yu J, Yang HP,
Wang HY, Zhang ZJ, Liu XP and Zou Q: CA IX is upregulated in
CoCl2-induced hypoxia and associated with cell invasive
potential and a poor prognosis of breast cancer. Int J Oncol.
48:271–280. 2016.
|
|
78
|
Konno H, Ishii G, Nagai K, Yoshida J,
Nishimura M, Nara M, Fujii T, Murata Y, Miyamoto H and Ochiai A:
Carbonic anhydrase IX expression is associated with tumor
progression and a poor prognosis of lung adenocarcinoma. Lung
Cancer. 54:409–418. 2006. View Article : Google Scholar
|
|
79
|
Le QT, Kong C, Lavori PW, O'byrne K, Erler
JT, Huang X, Chen Y, Cao H, Tibshirani R, Denko N, et al:
Expression and prognostic significance of a panel of tissue hypoxia
markers in head-and-neck squamous cell carcinomas. Int J Radiat
Oncol Biol Phys. 69:167–175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Haapasalo J, Hilvo M, Nordfors K,
Haapasalo H, Parkkila S, Hyrskyluoto A, Rantala I, Waheed A, Sly
WS, Pastorekova S, et al: Identification of an alternatively
spliced isoform of carbonic anhydrase XII in diffusely infiltrating
astrocytic gliomas. Neuro Oncol. 10:131–138. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Chen J, Röcken C, Hoffmann J, Krüger S,
Lendeckel U, Rocco A, Pastorekova S, Malfertheiner P and Ebert MP:
Expression of carbonic anhydrase 9 at the invasion front of gastric
cancers. Gut. 54:920–927. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Stewart DJ, Nunez MI, Behrens C, Liu D,
Lin YH, Lee JJ, Roth J, Heymach J, Swisher SG, Hong WK, et al:
Membrane carbonic anhydrase IX expression and relapse risk in
resected stage I–II non-small-cell lung cancer. J Thorac Oncol.
9:675–684. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Dubois L, Peeters SG, van Kuijk SJ,
Yaromina A, Lieuwes NG, Saraya R, Biemans R, Rami M, Parvathaneni
NK, Vullo D, et al: Targeting carbonic anhydrase IX by
nitroimidazole based sulfamides enhances the therapeutic effect of
tumor irradiation: A new concept of dual targeting drugs. Radiother
Oncol. 108:523–528. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Wojtkowiak JW, Verduzco D, Schramm KJ and
Gillies RJ: Drug resistance and cellular adaptation to tumor acidic
pH microenvironment. Mol Pharm. 8:2032–2038. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Koukourakis MI, Giatromanolaki A,
Danielidis V and Sivridis E: Hypoxia inducible factor (HIf1alpha
and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and
response of head-neck cancer to hypofractionated and accelerated
radiotherapy. Int J Radiat Biol. 84:47–52. 2008. View Article : Google Scholar
|
|
86
|
Lee-Kong SA, Ruby JA, Chessin DB,
Pucciarelli S, Shia J, Riedel ER, Nitti D and Guillem JG:
Hypoxia-related proteins in patients with rectal cancer undergoing
neoadjuvant combined modality therapy. Dis Colon Rectum.
55:990–995. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Span PN, Bussink J, Manders P, Beex LV and
Sweep CG: Carbonic anhydrase-9 expression levels and prognosis in
human breast cancer: Association with treatment outcome. Br J
Cancer. 89:271–276. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Tan EY, Yan M, Campo L, Han C, Takano E,
Turley H, Candiloro I, Pezzella F, Gatter KC, Millar EK, et al: The
key hypoxia regulated gene CAIX is upregulated in basal-like breast
tumours and is associated with resistance to chemotherapy. Br J
Cancer. 100:405–411. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Giatromanolaki A, Koukourakis MI, Sivridis
E, Pastorek J, Wykoff CC, Gatter KC and Harris AL: Expression of
hypoxia-inducible carbonic anhydrase-9 relates to angiogenic
pathways and independently to poor outcome in non-small cell lung
cancer. Cancer Res. 61:7992–7998. 2001.PubMed/NCBI
|
